- Contributing to the health of consumers around the world through both health food and skincare businesses
- Aim to become one of the largest health science companies in Asia-Pacific
- Together with Blackmores acquisition, increase Group value creation and further strengthen global operating base
TOKYO--(BUSINESS WIRE)-- Kirin Holdings Company, Limited (Kirin Holdings) (TOKYO: 2503) has decided to acquire additional shares of common stock of FANCL Corporation... (continue reading...)
Arm D of SEQUOIA study evaluated treatment-naïve patients with high-risk chronic lymphocytic leukemia or small lymphocytic lymphoma with del(17p) and/or TP53 mutation
Preliminary data suggest promising efficacy and tolerability
Safety profile was consistent with results of prior BRUKINSA studies
SAN MATEO, Calif.--(BUSINESS WIRE)-- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, announced the presentation of new data from... (continue reading...)
BOULDER, Colo.--(BUSINESS WIRE)-- Enveda Biosciences (“Enveda”), a biotechnology company using AI to translate nature into new medicines, announced today a new financing round of $55 million to add to its $119 million combined Series B and B1. New investors Premji Invest, Lingotto Investment Fund, Microsoft, and The Nature Conservancy participated in the round alongside existing investors Kinnevik, True Ventures, FPV, Level Ventures, and Jazz Venture... (continue reading...)
Tibulizumab (ZB-106) was well tolerated and neutralized IL-17A and BAFF in a Phase 1 study in patients with Sjogren’s syndrome
Preclinical data demonstrating the potential of dual inhibition of IL-17A and BAFF in a rheumatoid arthritis animal model support clinical development
HENDERSON, Nev.--(BUSINESS WIRE)-- Zura Bio Limited (Nasdaq: ZURA) (“Zura Bio”), a clinical-stage immunology company developing novel dual-pathway antibodies for autoimmune and... (continue reading...)
MANCHESTER, England--(BUSINESS WIRE)-- Manchester United plc (NYSE: MANU), will commence work to modernize the men’s first team building at Carrington Training Complex next week, with a focus on creating a high-performance collaborative environment for players and staff.
The £50 million project will result in all areas of the building being refurbished to deliver a world-class football facility with a positive culture to support future success.
The architectural... (continue reading...)
More Business Wire
View Older Stories-
Vertex Presents Positive Long-Term Data On CASGEVY™ (exagamglogene autotemcel) at the 2024 Annual European Hematology Association (EHA) Congress
-
ELREXFIO™ Shows Median Overall Survival of More Than Two Years in People with Relapsed or Refractory Multiple Myeloma
-
Immune-Onc Therapeutics to Present Additional Positive Interim Data from IO-202 Phase 1b Expansion Cohort in Patients with Chronic Myelomonocytic Leukemia (CMML) at 2024 European Hematology Associatio
-
Elliptic Labs Launching Its AI Virtual Proximity Sensor on the New HONOR Magic V Flip Smartphones
-
TotalEnergies Sells Its Subsidiary in Brunei
-
Tesla Releases Results of 2024 Annual Meeting of Stockholders
-
Matt Gallo of Gallo Vineyards Elected 2024-25 Wine Institute Chairman
-
Mitsubishi Electric to Ship Samples of GaN MMIC Power Amplifier for Ka-band SATCOM Earth Stations
-
NUBURU to Appeal NYSE Commencement of Proceedings to Delist
-
Data of InnoCare’s Robust Pipelines Presented at the European Hematology Association (EHA) 2024 Hybrid Congress
-
BeiGene and NewBridge Pharmaceuticals FZ LLC Mutually Agree to Conclude BRUKINSA® (Zanubrutinib) Partnership in the Middle East and Africa (MENA) Region
-
Riot Platforms, Inc. Reports Beneficial Ownership of 14% in Bitfarms Ltd.
-
Crescent Energy Announces Pricing of $750 Million Private Placement of 7.375% Senior Notes Due 2033
-
Ameresco to Celebrate the Commercial Operations of Kūpono Solar at Joint Base Pearl Harbor-Hickam
-
Canagold Resources Ltd. Announces Voting Results From Annual General Meeting
-
Celltrion showcases promising results in phase III study for CT-P47, a biosimilar candidate of RoActemra® (tocilizumab) in patients with rheumatoid arthritis (RA) at EULAR 2024
-
Careismatic Brands Successfully Completes Financial Restructuring Positioned for Continued Leadership in the Medical Apparel Industry
-
Sound Point Meridian Capital, Inc. Prices Initial Public Offering
-
GroundForce Capital Announces the Acquisition of OWYN by The Simply Good Foods Company
-
Innovative Solutions & Support, Inc. Response to Christopher Harborne Non-Binding Indication of Interest
-
Redwood Trust Prices $85.0 Million Senior Notes Offering
-
Freedom Holding Corp. Reports Fiscal Year 2024 Financial Results
-
Light & Wonder Announces Authorization of New $1 Billion Share Repurchase Program
-
Dry Goods Continues National Expansion; Set to Open Five New Stores in 2024
-
AeroVironment, Inc. Schedules Fourth Quarter and Full Fiscal Year 2024 Earnings Release and Conference Call
-
NASA’s Roman Mission Gets Cosmic ‘Sneak Peek’ From Argonne Supercomputer
-
Argonne Assembles Electric Vehicle Experts to Create Better Experiences at Charging Stations
-
Generation Mining Announces Results of Annual Meeting of Shareholders
-
Redwire Hires Distinguished Aerospace Executive and Corporate Attorney Aaron Futch as General Counsel
-
Purchase Capital Completes Sale of OWYN to Simply Good Foods
-
Fifth Third Bancorp Announces Cash Dividends
-
Cessna Citation Ascend Test Program Soars Ahead as Second Flight Test Article Successfully Takes Flight
-
U.S. Food and Drug Administration Approves Augtyro™ (repotrectinib), a Next-Generation Tyrosine Kinase Inhibitor (TKI), for the Treatment of Patients with NTRK-Positive Locally Advanced or Metastati
-
RH Reports First Quarter Fiscal 2024 Results
-
ReliaQuest promotes three teammates to key leadership positions to accelerate Go to Market growth
-
Colgate Declares Regular Quarterly Dividend
-
Forum Energy Technologies to Present at the J.P. Morgan 2024 Energy, Power and Renewables Conference
-
USA Compression Partners to Participate in J.P. Morgan Energy, Power & Renewables Conference
-
Granite Embarks on Rehabilitation Project Near Stratford, California
-
F9 Investments Releases Investor Presentation Highlighting Why Change Is Needed Urgently on LL Flooring’s Board of Directors
-
Novo Integrated Sciences Receives Confirmation of Issuance of SBLC by HSBC for SBLC Leasing and Monetizing Program
-
Chemours Names Tony Satterthwaite to Board of Directors
-
RYAM Senior Vice President of High Purity Cellulose to Participate in Fireside Chat
-
ComEd Readies for Severe Weather Across Northern Illinois
-
CyanVac Receives BARDA-Funded Project NextGen Award to Evaluate its Intranasal COVID-19 Vaccine Candidate in a Phase 2b Study
-
UDR Declares Quarterly Dividends
-
Apple Hospitality REIT Recognizes Top Performers with Apple Awards
-
Cherry Hill Mortgage Investment Corporation Announces Common and Preferred Dividends for the Second Quarter 2024
-
Build-A-Bear Workshop, Inc. Declares Quarterly Cash Dividend
-
Healthpeak Properties Publishes Its 13th Annual Corporate Impact Report